Highlights
About
Implantable Device for outpatient Chronic Heart Failure treatment and elimination of hospitalization
Clinical-stage company offers a disruptive outpatient treatment solution addressing the top global healthcare cost driver: recurring admissions of congested Chronic Heart Failure patients.
Our implanted, connected device removes excess fluid and salt and clears them to the patient’s bladder, providing continuous decongestion: personalized precise treatment with no patient involvement, out-of-hospital.
Clinical trials are underway with strong results from an initial series of patients.
Our target US market is 1.2M+ annual hospitalizations which generate $30B+ of hospital losses and payor costs, most of which are avoidable with our technology. ROW market is larger.
Identity
| Name | Paragate Medical |
|---|---|
| Slug | paragate-medical |
| Type / kind | startup |
| Crunchbase ID | paragate-medical |
| Source _id | agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgPf8zZcKDA |
Status
| Status | active |
|---|---|
| Last update | 2026-05-17 |
Location
| HQ country code | IL |
|---|---|
| HQ region/district | North District |
| HQ city | Haifa |
| HQ address | Derech HaAtsma'ut 57, Haifa, Israel |
Web & social
| Website | https://paragate-medical.com |
|---|---|
| https://www.linkedin.com/company/64274502 |
Classifications
Funding
| Total raised | $10.6M |
|---|---|
| Current stage | Seed |
Raw source document
Show full JSON (0 KB)
{
"0": "s",
"1": "l",
"2": "i",
"3": "m",
"4": "p",
"5": "a",
"6": "g",
"7": "e",
"8": "s",
"9": "_",
"10": "i",
"11": "m",
"12": "p",
"13": "o",
"14": "r",
"15": "t"
}